FDA Approves First New Alzheimer’s Drug in Decades | Miami News

FDA just approved lecanemab, the first new Alzheimer’s drug in decades, designed to slow cognitive decline by clearing amyloid plaques—offering hope for early-stage patients, though it’s not a cure and access, cost, and long-term effects remain key challenges. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/424d573d13d7cc6f